CA2792278C — 2,4-pyrimidinediamine compounds and prodrugs thereof and their uses
Assigned to Rigel Pharmaceuticals Inc · Expires 2019-05-14 · 7y expired
What this patent protects
The present disclosure provides biologically active 2,4-pyrimidinediamme compounds of formulae (I) and (II): and salts thereof, compositions comprising these compounds, and methods of using these compounds in a variety of applications.
USPTO Abstract
The present disclosure provides biologically active 2,4-pyrimidinediamme compounds of formulae (I) and (II): and salts thereof, compositions comprising these compounds, and methods of using these compounds in a variety of applications.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.